Skip to main content
Ed Silverman on Muck Rack

Ed Silverman

Verified
New Jersey
As seen in: Pharmalot Newsletter, STAT, Business Insider, Scribd, CNBC, PBS, PBS NewsHour, The Wall Street Journal, Boston.com, Scientific American, Flipboard, The Boston Globe and
Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps

Get in touch with Ed

Contact Ed, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Ed Silverman’s Biography

Read Full Bio →

Ed Silverman, senior writer and Pharmalot columnist, has covered the pharmaceutical industry for the past two decades. He previously worked at The Wall Street Journal, The Star-Ledger of New Jersey, New York Newsday and Investor’s Business Daily, among other publications. Ed earned an accounting degree from Binghamton University and a master’s in journalism from New York University. He enjoys reading, spending time with his family, and walking the official Pharmalot mascots.

Articles

Obesity’s Marketing Playbook Is Colliding With Europe’s Advertising Red Lines

|
By Ed Silverman Verified
| Citeline Verified
France’s ANSM fined Novo Nordisk and Eli Lilly over obesity “awareness” campaigns it says crossed into banned direct-to-consumer promotion. With probes opening across Europe and fines dwarfed by drug revenue, the test is whether enforcement can keep pace with the gold rush. Obesity educational campaign on the London Underground. Credit: Anabel Costa Ferreira.
Open in Who Shared Issue with article?

The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations

|
By Elaine Chen, Ed Silverman Verified, Theresa Gaffney Verified
| EIN News
NEW YORK — Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data. There were slightly fewer than 5.4 infant deaths per 1,000 live births in 2025, according to the Centers for Disease Control and Prevention. While that appears to be a small decline from about 5.5 in 2024 and 5.6 in the two years preceding, researchers say it is statistically meaningful and translates to hundreds of fewer infant deaths per year.
Open in Who Shared View Duplicates (253) Issue with article?

STAT — Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more

|
By Ed Silverman Verified
| Friends of Cancer Research
Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are wafting over the Pharmalot campus, where the official mascots are snoozing in their respective corners. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is wild mountain blueberry, a summer treat. Please feel free to join us. Meanwhile, here is the latest menu of tidbits to help you get started yourself.
Open in Who Shared Issue with article?
See all 1,264 licensed articles (7,950 Total)